Labiotech.eu

News and Trends 10 Feb 2022

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

An international academic team has made strides in carrying out genome sequencing faster and more cheaply in low- and middle- income nations. This could improve the control of potentially lethal salmonella infections and propel research into vaccines. As the price of DNA sequencing continues to fall, genomics and bioinformatics firms are drawing ever more attention […]

February 10, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 8 Feb 2022

Reforms of EU Clinical Trial Regulations Bring Cautious Optimism

The EU’s clinical trial regulations received a major overhaul at the end of January 2022 to make trials easier to run across EU member states. It may bring some short-term chaos, industry insiders say, but down the road it is likely to pay off. At the start of February, the EU’s new Clinical Trials Regulation […]

February 8, 2022 - 5 minutesmins - By Victor Kotsev

January Financial Top European Investments

News and Trends 3 Feb 2022

The Top European Biotech Investments in January 2022

Viral infection treatments, cell therapy, and artificial intelligence led biotech investments in January 2022 as the European sector took a collective breather from December’s funding frenzy. European biotech investments started 2022 at a modest level compared to the huge cash flow seen in November and December 2021. While December 2021 saw almost €1.6B money raised, […]

February 3, 2022 - 3 minutesmins - By Jonathan Smith

ethris mrna therapy respiratory infection

News and Trends 1 Feb 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Thanks to Covid-19 vaccines, messenger RNA (mRNA) technology has reached the mainstream. With a €23.4M Series B round, the German firm Ethris is riding the mRNA buzz by developing inhalable mRNA therapies for respiratory diseases. As Covid-19 mRNA vaccines entered the market for the first time in 2020, the wide potential of mRNA technology became […]

February 1, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 1 Feb 2022

Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A

The Viennese biotech startup Ribbon Biolabs has raised an €18M Series A round to reduce the costs of synthesizing long DNA molecules, which could accelerate research into synthetic biology and the storage of data as DNA. Supported by lead investor Hadean Ventures, Ribbon Biolabs’ fundraising round is part and parcel of a continuing investor interest […]

February 1, 2022 - 3 minutesmins - By Dan Samorodnitsky

In Depth 31 Jan 2022

Nature’s Painters: Making Sustainable Colors with Microbes

The production of textile dyes and food colorants can have a big environmental footprint. Biotech startups are rising to the challenge by engineering bacteria, fungi, and algae to sustainably produce natural colors. Eight years ago, University of Cambridge researcher Jim Ajioka was in Nepal helping to produce a biosensor to detect arsenic in drinking water […]

January 31, 2022 - 9 minutesmins - By Helen Albert

News and Trends 28 Jan 2022

AI Hot in Healthcare Despite IBM’s Watson Health Pullout

Earlier this week, the tech giant IBM sold off chunks of its once-promising artificial intelligence (AI)-guided division Watson Health. Despite this setback, European firms see a bright future for the use of AI in healthcare. The tech giant IBM hit the headlines this week when it sold off parts of Watson Health — a division […]

January 28, 2022 - 4 minutesmins - By Jonathan Smith

norway cytovation cancer immuno oncology

News and Trends 26 Jan 2022

Norwegian Biotech Put on the Map with €18M Oncology Round

The immuno-oncology startup Cytovation has raised €17.7M (NOK 180M) in one of Norway’s biggest Series A rounds in life sciences. Historically, Norway’s biotech scene has not seen the kind of venture capital funding characteristic of health and biotech in the UK and US. However, Norwegian biotech is growing and has seen more successes than many […]

January 26, 2022 - 3 minutesmins - By Dan Samorodnitsky

News and Trends 26 Jan 2022

Bioinformatics Startups in Focus as SeqOne Genomics Bags €20M

The French company SeqOne Genomics has raised €20M in a Series A round as growing investments reach startups delivering the next generation of genomics and bioinformatics. The cost of sequencing the human genome has plummeted over the decades to less than €900 ($1,000) today. Partly thanks to advances in cloud computing, innovations are flourishing in […]

January 26, 2022 - 4 minutesmins - By Jonathan Smith

Merck, drug development, lab work, lab worker, scientist

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

Biotech firms partner with contract development and manufacturing organizations (CDMOs) to leverage their expertise in process development, optimization, and scale-up. In this article, we share an exclusive sneak-peek into a recent survey, which explores the main reasons why biotech companies collaborate with CDMOs at different stages of drug development. To make a new drug candidate […]

January 26, 2022 - 8 minutesmins - By Sudha Sundaram

Kees Melief Chief Scientific Officer ISA Pharmaceuticals

Expert Advice 24 Jan 2022

Transitioning from Academia to Chief Scientific Officer in the Biotech Industry

Academics with a drive to turn their research into commercial products often end up in the position of Chief Scientific Officer at a biotech company. Kees Melief shares his own personal experience transitioning from academia to industry. After his retirement as an academic researcher at Leiden University, Cornelis ‘Kees’ Melief founded and became the Chief […]

January 24, 2022 - 5 minutesmins - By Victor Kotsev

Gene therapy genenta science genflow biosciences

News and Trends 21 Jan 2022

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

After a drought of more than a year, the European gene therapy sector saw initial public offerings from Genenta Science and Genflow Biosciences. The firms aim to shine as biotech stocks elsewhere perform poorly. Until recently, European gene therapy companies were going through a dry spell in terms of launching initial public offerings (IPO). The […]

January 21, 2022 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

Reforms of EU Clinical Trial Regulations Bring Cautious Optimism

The Top European Biotech Investments in January 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A

Nature’s Painters: Making Sustainable Colors with Microbes

AI Hot in Healthcare Despite IBM’s Watson Health Pullout

Norwegian Biotech Put on the Map with €18M Oncology Round

Bioinformatics Startups in Focus as SeqOne Genomics Bags €20M

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

Transitioning from Academia to Chief Scientific Officer in the Biotech Industry

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!